HSE patients had reduced expression of TLR3-TRIF-TRAF3-dependent antiviral response type I interferon, which is consistent with their susceptibility to herpes simplex virus infection [97–100]. The gene discussed is TRAF3; the disease is herpes simplex encephalitis.